parkinsons and glutathione Enhanced accumulation of reduced by Scopoletin improves survivability of dopaminergic neurons in Parkinson's model Glutathione S-transferase: A keystone in

16: One of the most-anticipated FDA decisions of the first half of 2024 came early as the regulator approved Vertex Pharmaceuticals and CRISPR Therapeutics Casgevy (exagamglogene autotemcel) as a one-time treatment for transfusion-dependent beta-thalassemia (TDT)

Compared with all the other treatments, the application of the ChPut nanocomposite at a concentration of 2.5 mM resulted in a substantial increase in the GSH content in the chilled plants

doi: 10.3389/fnmol.2025.1648047 Received 17 June 2025 Accepted 25 September 2025 Published 23 October 2025 Volume 18 - 2025 Edited by Pavlo Petakh, Uzhhorod National University, Ukraine Reviewed by Amanda Alves Marcelino Da Silva, Universidade de Pernambuco, Brazil Chayan Munshi, Ethophilia Research Foundation, India Updates Copyright 2025 Zhang, Mao, Chen, Wang, Wu and Wang

The IV format typically allows for a large spike in blood levels which helps drive key mood regulating substances into the brain

Are comfortable with emerging and evolving research: Longevity medicine is a frontier field